HTSC's Research Reports point out that Winner Medical (300888.SZ) is a big health enterprise positioned as "Consumer + Medical" dual-driven, with an upward operating turning point. Initiated coverage with a "Buy" rating and a Target Price of 48.44 yuan. Looking ahead: 1) The Consumer sector insists on a product-leading Global Strategy, integrating marketing for precise investment, and the Operation is gradually improving, with both online/offline and non-woven/woven fully exerting effort, accelerating growth in 2024, Bullish on the growth potential of the Consumer Sector. 2) In the Medical Sector, the high base of infection protection supplies has been fully digested, and Q3 has returned to normal growth; the growth of regular products is accelerating, with bidirectional efforts in internal and external development, expected to benefit from the Industry expansion.